Nifty 50
- HCL Technologies₹1,320.1097.10 (7.94%)
- Kotak Mahindra Bank₹439-4.40 (-0.99%)
- TCS₹2,269.30144.30 (6.79%)
- Eternal₹320.45-2.55 (-0.79%)
- Shriram Finance₹986.2056.80 (6.11%)
- Max Healthcare₹861-4.95 (-0.57%)
- Tech Mahindra₹1,538.9067.90 (4.62%)
- Maruti Suzuki₹11,259-56.00 (-0.49%)
- Infosys₹1,061.1541.15 (4.03%)
- HDFC Life Insurance ₹558.05-1.20 (-0.21%)
- Hindustan Unilever₹1,876.6055.90 (3.07%)
- Nestle₹1,324.10-0.60 (-0.05%)
- Bajaj Auto₹10,336302.00 (3.01%)
- Bajaj Finance₹982.7525.50 (2.66%)
- Trent₹2,985.9072.90 (2.50%)
- Adani Enterprises₹2,69565.00 (2.47%)
- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Margin Pledge Calculator
- Algo Strategy
- Markets
Stocks
F&O
Mutual Funds
- More
Quant MF Sells Jubilant Pharmova Stake for Over Rs 100 Crore; Stock Falls Over 2%
Authored By PTI | Published at: Oct 13, 2026 03:45 PM IST

Open Free Demat Account
Open Free Demat Account
New Delhi: Quant Mutual Fund has sold nearly 1 per cent stake in Jubilant Pharmova for over Rs 100 crore through an open market transaction, according to NSE data.
Quant Mutual Fund (Quant MF) offloaded 11 lakh shares, representing a 0.69 per cent stake in the Noida-based drugmaker, as per block deal data on the National Stock Exchange (NSE).
The transaction was executed on Monday at an average price of Rs 915 apiece, taking the deal value to Rs 100.65 crore.
The stake sale reduced Quant MF’s holding in Jubilant Pharmova to 1.16 per cent from 1.85 per cent.
Meanwhile, Abakkus Four2Eight Opportunities Fund, an alternative investment fund launched by Sunil Singhania’s Abakkus Asset Manager, acquired the same number of shares at the same price.
The purchase increased Abakkus Asset Manager’s holding in the pharmaceutical company to 1.84 per cent from 1.15 per cent.
Jubilant Pharmova’s shares fell 2.32 per cent to Rs 928.80 on the NSE on Tuesday, after the transaction was executed a day earlier.
Separately, Jubilant Pharmova’s board has approved raising of up to Rs 800 crore through the issuance of non-convertible debentures on a private placement basis, according to a regulatory filing on Monday.
Jubilant Pharmova has businesses spanning radiopharmaceuticals, allergy
immunotherapy, contract development and manufacturing of sterile injectables, contract research and development, generics and proprietary novel drugs.
(Disclaimer: Except for the headline, this article has not been edited by HDFC Sky editorial team and is auto-generated from PTI feed.)
Disclaimer
The information shared here is intended solely for informational and educational purposes and does not constitute investment recommendations. While we practice strict due diligence in curating daily market data, readers must perform independent research before trading. To flag any real-time data discrepancies or content concerns, please write to us at content@hdfcsec.com.
More JUBLPHARMA News
Open Free Demat Account
Open Free Demat Account
₹950





By signing up I certify terms, conditions & privacy policy
Join Us
Add as preferred source on Google









